SILINI, Enrico Maria
 Distribuzione geografica
Continente #
NA - Nord America 11.234
EU - Europa 10.142
AS - Asia 9.918
SA - Sud America 1.420
AF - Africa 498
Continente sconosciuto - Info sul continente non disponibili 306
OC - Oceania 11
Totale 33.529
Nazione #
US - Stati Uniti d'America 10.887
IT - Italia 5.103
SG - Singapore 3.495
CN - Cina 2.704
VN - Vietnam 1.462
BR - Brasile 1.103
IE - Irlanda 1.018
SE - Svezia 815
HK - Hong Kong 737
DE - Germania 572
FI - Finlandia 566
BD - Bangladesh 539
FR - Francia 501
UA - Ucraina 433
NL - Olanda 386
ZA - Sudafrica 354
TR - Turchia 247
GB - Regno Unito 198
CA - Canada 187
IN - India 157
RU - Federazione Russa 146
AR - Argentina 116
AT - Austria 81
IQ - Iraq 80
MX - Messico 74
JP - Giappone 64
PL - Polonia 59
EC - Ecuador 48
ES - Italia 47
PH - Filippine 45
KR - Corea 44
CZ - Repubblica Ceca 42
PK - Pakistan 41
CO - Colombia 38
ID - Indonesia 38
BE - Belgio 37
TH - Thailandia 32
UZ - Uzbekistan 30
VE - Venezuela 30
CH - Svizzera 28
IL - Israele 28
MA - Marocco 24
SA - Arabia Saudita 21
CL - Cile 20
EG - Egitto 20
CI - Costa d'Avorio 19
PY - Paraguay 19
LT - Lituania 18
KE - Kenya 17
TN - Tunisia 16
UY - Uruguay 16
PE - Perù 15
TW - Taiwan 15
AZ - Azerbaigian 14
JO - Giordania 14
KZ - Kazakistan 14
BO - Bolivia 13
PA - Panama 13
PT - Portogallo 13
DK - Danimarca 12
AE - Emirati Arabi Uniti 11
HN - Honduras 11
DZ - Algeria 10
GT - Guatemala 10
JM - Giamaica 10
MY - Malesia 10
RO - Romania 10
CR - Costa Rica 9
OM - Oman 9
DO - Repubblica Dominicana 8
EU - Europa 8
NP - Nepal 8
LB - Libano 7
TT - Trinidad e Tobago 7
AL - Albania 6
CG - Congo 6
ET - Etiopia 6
GR - Grecia 6
HR - Croazia 6
IR - Iran 6
KW - Kuwait 6
NG - Nigeria 6
PS - Palestinian Territory 6
SN - Senegal 6
AO - Angola 5
AU - Australia 5
BY - Bielorussia 5
HU - Ungheria 5
KH - Cambogia 5
LA - Repubblica Popolare Democratica del Laos 5
LY - Libia 5
NZ - Nuova Zelanda 5
RS - Serbia 5
SV - El Salvador 5
CY - Cipro 4
KG - Kirghizistan 4
LK - Sri Lanka 4
XK - ???statistics.table.value.countryCode.XK??? 4
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
Totale 33.185
Città #
Singapore 1.738
Ashburn 1.373
San Jose 1.089
Chandler 1.055
Dublin 1.014
Hong Kong 702
Santa Clara 699
Beijing 679
Dallas 557
Ho Chi Minh City 475
Jacksonville 413
Council Bluffs 397
Milan 351
Hanoi 343
Boardman 342
Dearborn 334
Johannesburg 325
New York 288
Rome 284
Parma 283
Los Angeles 244
Ann Arbor 239
Nanjing 234
Lauterbourg 215
Princeton 205
Shanghai 205
Izmir 188
Munich 149
Wilmington 141
Hefei 133
San Mateo 128
Naples 106
Bologna 102
Helsinki 98
São Paulo 97
Shenyang 91
Buffalo 90
Nanchang 88
Moscow 84
Jinan 82
Toronto 78
Kunming 75
Chicago 71
Columbus 63
Tianjin 60
Houston 58
Vienna 58
Guangzhou 55
Turin 55
Bremen 54
Haiphong 54
Turku 54
Da Nang 53
Florence 52
Hebei 51
Frankfurt am Main 50
Jiaxing 49
Warsaw 48
Tokyo 46
Orem 45
Seattle 43
Marseille 42
Catania 41
Palermo 41
Rio Saliceto 41
Nuremberg 40
London 39
Montreal 39
Bari 38
Changsha 36
Napoli 36
Brooklyn 35
Des Moines 34
Chennai 33
Atlanta 31
Brussels 31
Genoa 31
Seoul 31
Brescia 30
Modena 30
Tashkent 29
Baghdad 28
Rio de Janeiro 28
The Dalles 28
Denver 26
Phoenix 26
Reggio Emilia 26
Stockholm 26
Biên Hòa 25
Can Tho 25
Monza 25
Hangzhou 24
Belo Horizonte 23
Genova 23
Hải Dương 23
San Francisco 23
Zhengzhou 23
Amsterdam 22
Chengdu 22
Norwalk 22
Totale 18.008
Nome #
EVOLUZIONE ATIPICA DI UN CASO DI LEIOMIOMA METASTATIZZANTE BENIGNO POLMONARE 2.547
TUMORE FIBROSO SOLITARIO MALIGNO DELLA PLEURA ASSOCIATO A SEVERA IPOGLICEMIA: LA SINDROME DI DOEGE-POTTER 1.925
Angiosarcoma epitelioide della tiroide con metastasi polmonari: follow up a 1 anno 369
LIPOSARCOMA DEDIFERRENZIATO MEDIASTINICO GIGANTE: UN RISCONTRO ESTREMAMENTE RARO 350
3D assessment of the Umbilical Vein Deviation Angle (UVDA) for the prediction of liver herniation in Left Congenital Diaphragmatic Hernia 253
Anti-Viral Intrahepatic T-Cell Responses can be Restored by Blocking Programmed Death-1 Pathway in Chronic Hepatitis B 214
ANASTOMOTIC RECURRENCE OF COLON CANCER: GENETIC ANALYSIS CHALLANGES THE WIDELY HELD THEORIES OF CANCEROUS CELLS’ INTRALUMINAL IMPLANTATION AND METACHRONOUS CARCINOGENESIS 212
Incidence of neuroepithelial primary brain tumors among adult population of Emilia-Romagna Region, Italy 208
Correlations between tumor-infiltrating and circulating lymphocyte subpopulations in advanced renal cancer patients treated with nivolumab 208
Low PD-1 expression in Cytotoxic CD8+ Tumor infiltrating Lymphocytes Confers an Immune Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value 206
Correction to: Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study 200
Notch-Jagged1 signaling and response to bevacizumab therapy in advanced colorectal cancer: A glance to radiomics or back to physiopathology? 199
Immunomodulatory effects of antiangiogenic tyrosine kinase inhibitors in renal cell carcinoma models: Impact on following anti-PD-1 treatments 197
Genetics of Darier’s Disease: New Insights into Pathogenic Mechanisms 190
Accuracy of fine needle aspiration cytology in the pathological typing of non-small cell lung cancer. 189
Survival prediction in high-grade gliomas using CT perfusion imaging 188
PREDICTIVE AND PROGNOSTIC VALUE OF CLINICAL AND MOLECULAR FEATURES IN PATIENTS UNDERGOING PULMONARY METASTASECTOMY FROM RENAL CELL CARCINOMA 183
Histological subtype analysis of colon cancer: a population-based study. Different sides and different diseases. 182
Prognostic modeling of oral cancer by gene profiles and clinicopathological co-variables 181
Impact of laterality and mucinous histology on relapse-free and overall survival in a registry-based colon cancer series 181
Pulmonary metastasectomy for colorectal cancer: Analysis of prognostic factors affecting survival 176
A regional audit system for stillbirth: A way to better understand the phenomenon 175
ACCURACY OF CYTOLOGY IN THE IDENTIFICATION OF HISTOLOGIC SUBTYPE IN NON-SMALL CELL LUNG CANCER (NSCLC 173
Thyroid cancer incidence by histological type and related variants in a mildly iodine-deficient area of Northern Italy, 1998 to 2009. 172
Pleural tuberculosis: medical thoracoscopy greatly increases the diagnostic accuracy 172
Emergence of a HER2-amplified clone during disease progression in an ALK-rearranged NSCLC patient treated with ALK-inhibitors: A case report 170
CARCINOMA NEUROENDOCRINO PRIMITIVO DEL MEDIASTINO 169
Resistance to osimertinib in advanced EGFR-mutated NSCLC: a prospective study of molecular genotyping on tissue and liquid biopsies 168
18F-FDG and 68GA-Prostate-Specific Membrane Antigen PET/CT Perform Better Than CT Alone in Restaging Papillary Renal Cell Carcinoma Recurrence 168
Neoplasie del polmone in Neoplasie del Distretto Toracico 166
Associazione di ipotiroidismo e carcinoma papillare della tiroide variante sclerosante diffusa 165
Definition of miRNAs Expression Profile in Glioblastoma Samples: The Relevance of Non-Neoplastic Brain Reference 165
Lung mesenchymal cells function as an inductive microenvironment for human lung cancer propagating cells† 164
Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study 163
Adenocarcinoma of the Lung Metastatic to the Ovary With a Signet Ring Cell Component 162
Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III 162
Complex tumours genomic and transcriptomic analysis in uterine tumours resembling ovarian sex cord tumours (UTROSCT). 161
CAD204520 Targets NOTCH1 PEST Domain Mutations in Lymphoproliferative Disorders 161
Ovarian metastasis from renal clear cell carcinoma: A case report with an intra-operative, immunohistochemical study and a review of the literature 161
Isolation and characterization of human lung lymphatic endothelial cells 161
Resolution of late-onset heart and liver failures after reversion of jejuno-ileal bypass: a case report 160
Intersecting Blood Cytokines With Cholesterol Parameters to Profile Patients With Advanced Solid Tumors Receiving Immune Checkpoint Inhibitors 159
Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-volume center? 159
The prognostic value of the haemoglobin/red cell distribution width ratio in a cohort of pre-treated patients with renal cell carcinoma receiving nivolumab 158
Prognostic value of [18F]FDG PET/CT parameters in surgically resected primary lung adenocarcinoma: a single-center experience 157
Antibody responses to hepatitis C virus hypervariable region 1: Evidence for cross-reactivity and immune-mediated sequence variation 156
Retrospective immunophenotypical evaluation of MET, PD-1/PD-L1, and mTOR pathways in primary tumors and pulmonary metastases of renal cell carcinoma: the RIVELATOR study addresses the issue of biomarkers heterogeneity 155
Antibody responses to hepatitis C virus hypervariable region 1: evidence for cross-reactivity and immune-mediated sequence variation 155
Spatial architecture of tumour-infiltrating lymphocytes as a prognostic parameter in resected non-small-cell lung cancer 154
Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1. 153
MEDIASTINITE FIBROSANTE ASSOCIATA A GRNULOMATOSI DI WEGENER 153
Adenomatous polyposis coli gene involvement in ileal enterochromaffin cell neuroendocrine neoplasms. 152
Correlation between erlotinib pharmacokinetics, cutaneous toxicity and clinical outcomes in patients with advanced non-small cell lung cancer (NSCLC) 151
Multiple primary malignancies involving lung cancer: a single-center experience 150
Immune gene expression profile in hepatocellular carcinoma and surrounding tissue predicts time to tumor recurrence 149
Primary Epithelioid Angiosarcoma of the Thyroid in a Patient Occupationally Exposed to Radiations 149
Molecular classification using Lund University algorithm and clinical correlations in muscle-invasive bladder cancer: Insights from a retrospective study 148
Analysis of hepatitis C virus hypervariable region 1 sequence from cryoglobulinemic patients and associated controls 148
Immune context characterization and heterogeneity in primary tumors and pulmonary metastases from renal cell carcinoma 147
Small renal masses (≤ 4 cm): differentiation of oncocytoma from renal clear cell carcinoma using ratio of lesion to cortex attenuation and aorta–lesion attenuation difference (ALAD) on contrast-enhanced CT 146
Risk stratification and prediction of locoregional recurrence in patients affected by oral squamous cell carcinoma (OSCC): the Neomark Project interim results. 145
The NeoMark Project interim results: integration of heterogeneous data for prediction of oral squamous cell cancer (OSCC) recurrence. 145
A case of biliary adenofibroma with malignant transformation 145
Associazione di ipotiroidismo autoimmune e carcinoma papillare della tiroide variante sclerosante diffusa. 144
Oncocytic osteolipoadenoma of the submandibular gland 144
Sarcoid-like reaction mimicking disease progression in an ALK-positive lung cancer patient receiving lorlatinib 144
ANALYSIS OF MICRORNA EXPRESSION IN MALIGNANT PLEURAL MESOTHELIOMA, ASBESTOSIS AND BENIGN PULMONARY DISEASE: A PRELIMINARY STUDY 143
Prognostic impact of interval breast cancer detection in women with pT1aN0M0 breast cancer with HER2-positive status: results from a multicenter population-based cancer registry study 143
Chronic periaortitis associated with membranous nephropathy: clues to common pathogenetic mechanisms. 142
Antibody-negative chronic hepatitis C virus infection in immunocompetent children 142
Glutamine depletion by crisantaspase hinders the growth of human hepatocellular carcinoma xenografts 142
Antibody responses to the hepatitis C virus (HCV) E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjects 141
Diagnostic Criteria of Pediatric Intestinal Myopathies 140
Relationship Between the Diffusing Capacity of the Lung for Carbon Monoxide (DLCO) and Lung Adenocarcinoma Patterns: New Possible Insights 139
Clinico-pathological features of two new cases of Uterine Tumours Resembling Ovarian Sex Cord Tumours (UTROSCTs) 139
Vascular liver injury mimicking an intrahepatic cholangiocarcinoma in a COVID-19 patient 139
Integration of clinical, histopathological, radiological and biomolecular data for prediction of oral squamous cell cancer (OSCC) recurrence: the NeoMark Project’s first report. 139
p16 genetic and epigenetic alterations in head and neck squamous cell carcinomas (HNSCC). 139
Primary alveolar soft part sarcoma of uterine corpus: a case report with immunohistochemical, ultrastructural study and review of literature 139
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) Syndrome and Carcinoid Tumors With/Without NECH: A Clinicopathologic, Radiologic, and Immunomolecular Comparison Study 139
Congenital cervical teratoma: a case report 138
Squamotransitional cell carcinoma of the vagina: Diagnosis and clinical management - A literature review starting from a rare case report 138
Testicular metastasis of prostate adenocarcinoma: the other side of orchiepididymitis 137
EXCEPTIONAL EVOLUTION OF BENIGN METASTASIZING LEIOMYOMAS OF THE LUNG 137
microRNAs Expression in Malignant Pleural Mesothelioma, Asbestosis and Benign Pulmonary Disease 137
Comparison of HER2 status in primary and paired metastatic sites of gastric carcinoma 136
Sentinel node in oral cancer: The nuclear medicine aspects. A survey from the sentinel European node trial 136
Exclusive periductal/pericystic growth pattern in a case of long-standing monophasic synovial sarcoma of the parotid gland 136
Prognostic impact of interval breast cancer detection in women with pT1a N0M0 breast cancer with HER2-positive status: Results from a multicentre population-based cancer registry study 136
An heteroduplex mobility analysis assay based on capillary electrophoresis in the study of HCV quasispecies 135
miRNAs expression analysis in paired fresh/frozen and dissected formalin fixed and paraffin embedded glioblastoma using real-time pCR. 135
Randomized, open-label, phase II, biomarker study of immune-mediated mechanism of action of neoadjuvant subcutaneous trastuzumab in patients with locally advanced, inflammatory, or early HER2-positive breast cancer-Immun-HER trial (GOIRC-01-2016) 134
Implications of a positive sentinel node in oral squamous cell carcinoma. 134
Epilepsy in primary cerebral tumors: The characteristics of epilepsy at the onset (results from the PERNO study-Project of Emilia Romagna Region on Neuro-Oncology) 134
Size of thyroid carcinoma by histotype and variants: A population-based study in a mildly iodine-deficient area 134
Giant intercostal nerve schwannoma in a patient with neurofibromatosis type 2 134
Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors 134
Role of innate and adaptive immunity in the efficacy of anti-HER2 monoclonal antibodies for HER2-positive breast cancer 133
Optimizing PD-L1 evaluation on cytological samples from advanced non-small-cell lung cancer 133
Integration of clinical, histopathological, radiological and biomolecular data for prediction of oral cancer recurrence: the NeoMark Project’s first report. 133
Totale 20.312
Categoria #
all - tutte 112.447
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 112.447


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.166 0 52 49 53 44 42 129 152 81 131 83 350
2022/20234.259 394 462 268 296 306 482 96 311 1.316 57 188 83
2023/20242.078 155 173 89 86 148 366 132 178 105 141 204 301
2024/20255.691 160 292 402 336 586 630 268 257 716 559 499 986
2025/202612.807 1.159 1.051 1.424 1.119 1.716 672 1.381 523 1.457 932 823 550
2026/2027786 321 465 0 0 0 0 0 0 0 0 0 0
Totale 33.529